Work

Markers of bone metabolism predict survival in hormone refractory prostate cancer (HRPC): Results from a randomized California Cancer Consortium & University of Chicago trial

Year: 2005

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2005.23.16_suppl.4569

Authors: P. N. Lara, J. Longmate, W. Stadler, M. van Loan, J. Wexler, D. I. Quinn, P. Twardowski, E. E. Vokes, D. R. Gandara

Institutions: University of Southern California, City Of Hope National Medical Center, University of Chicago, City of Hope, University of California Davis Medical Center, UC Davis Comprehensive Cancer Center, University of California, Davis

Language: English

Topic: Bone health and treatments

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2323700153

Cites:

Cited by: 4

Related to: 10